MAPK10 Human

Mitogen-Activated Protein Kinase 10 Human Recombinant
Cat. No.
BT10906
Source

Sf9, Baculovirus cells.

Synonyms

C-Jun N-Terminal Kinase 3, MAP Kinase P49 3F12, MAP Kinase 10, PRKM10, SAPK1b, JNK3A, JNK3.

Appearance
Sterile Filtered colorless solution.
Purity

Greater than 85.0% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

MAPK10 produced in Sf9 Insect cells is a single, glycosylated polypeptide chain containing  470 amino acids (1-464 a.a.) and having a molecular mass of  53.4kDa.

MAPK10 is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
MAPK10, a member of the MAP kinase family, acts as a central point for various biochemical pathways. It plays a crucial role in cellular processes such as differentiation, proliferation, development, and transcriptional regulation.
Description
MAPK10, produced in Sf9 insect cells, is a single, glycosylated polypeptide chain with a molecular weight of 53.4 kDa. It consists of 470 amino acids (1-464 a.a.). The protein is expressed with a 6-amino acid His tag at the C-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
MAPK10 is supplied as a 0.25 mg/ml protein solution in Phosphate Buffered Saline (pH 7.4) containing 30% glycerol, 1mM DTT, and 0.1mM PMSF.
Stability
For short-term storage (2-4 weeks), store at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 85.0% as determined by SDS-PAGE.
Synonyms

C-Jun N-Terminal Kinase 3, MAP Kinase P49 3F12, MAP Kinase 10, PRKM10, SAPK1b, JNK3A, JNK3.

Source

Sf9, Baculovirus cells.

Amino Acid Sequence

MSLHFLYYCS EPTLDVKIAF CQGFDKQVDV SYIAKHYNMS KSKVDNQFYS VEVGDSTFTV LKRYQNLKPI GSGAQGIVCA AYDAVLDRNV AIKKLSRPFQ NQTHAKRAYR ELVLMKCVNH KNIISLLNVF TPQKTLEEFQ DVYLVMELMD ANLCQVIQME LDHERMSYLL YQMLCGIKHL HSAGIIHRDL KPSNIVVKSD CTLKILDFGL ARTAGTSFMM TPYVVTRYYR APEVILGMGY KENVDIWSVG CIMGEMVRHK ILFPGRDYID QWNKVIEQLG TPCPEFMKKL QPTVRNYVEN RPKYAGLTFP KLFPDSLFPA DSEHNKLKAS QARDLLSKML VIDPAKRISV DDALQHPYIN VWYDPAEVEA PPPQIYDKQL DEREHTIEEW KELIYKEVMN SEEKTKNGVV KGQPSPSGAA VNSSESLPPS SSVNDISSMS TDQTLASDTD SSLEASAGPL GCCRHHHHHH.

Product Science Overview

Introduction

Mitogen-Activated Protein Kinase 10 (MAPK10), also known as c-Jun N-terminal kinase 3 (JNK3), is a member of the MAP kinase family. This family of kinases plays a crucial role in various cellular processes, including proliferation, differentiation, transcription regulation, and development. MAPK10 is specifically expressed in a subset of neurons in the nervous system and is activated by threonine and tyrosine phosphorylation .

Gene and Protein Structure

The MAPK10 gene is located on chromosome 4 and encodes a protein that is part of the c-Jun N-terminal kinases (JNK) subgroup within the MAPK superfamily . The protein is a serine/threonine-specific kinase involved in various processes such as neuronal proliferation, differentiation, migration, and programmed cell death .

Function and Significance

MAPK10 acts as an integration point for multiple biochemical signals, making it essential for various cellular responses. It is particularly significant in the nervous system, where it is involved in stress-induced neuronal apoptosis . The kinase is activated by extracellular stimuli such as pro-inflammatory cytokines or physical stress, which stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway .

Clinical Relevance

MAPK10 has been implicated in several diseases, including Lennox-Gastaut Syndrome and Developmental and Epileptic Encephalopathy 94 . Recent studies have also suggested that MAPK10 may function as a tumor suppressor in hepatocellular carcinoma (HCC). The protein expression of MAPK10 is significantly downregulated in clinical samples of HCC patients compared to adjacent normal tissues . This downregulation is often due to epigenetic modifications such as methylation, which silences the gene .

Research and Therapeutic Potential

The role of MAPK10 in various diseases makes it a potential target for therapeutic interventions. For instance, reversing the methylation of MAPK10 in HCC cell lines has been shown to inhibit colony formation, induce apoptosis, and enhance chemosensitivity to 5-fluorouracil . These findings suggest that MAPK10 could be a valuable biomarker or therapeutic target in clinical settings .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.